Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion type Assertion NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_head.
- NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion description "[HER-2/neu-dependent differential expression of PGK1, FASN, Hsp27, and GLO was further validated in four breast cancer cell lines and 12 breast tumors by immunoblotting and confirmed by partially switching off the HER-2/neu signaling in the high HER-2/neu-expressing SKBr3 cell line with Herceptin treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_provenance.
- NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion evidence source_evidence_literature NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_provenance.
- NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion SIO_000772 16048908 NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_provenance.
- NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion wasDerivedFrom befree-20150227 NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_provenance.
- NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_assertion wasGeneratedBy ECO_0000203 NP428661.RAg08kXoI5C0titDy4o-JV9ngaUcDRYHY-TwqZ0BYCuXg130_provenance.